ECSP066727A - Reacciones de acoplamiento útiles en la preparación de derivados de (1h-tetrazol-5-il)-bifenilo - Google Patents

Reacciones de acoplamiento útiles en la preparación de derivados de (1h-tetrazol-5-il)-bifenilo

Info

Publication number
ECSP066727A
ECSP066727A EC2006006727A ECSP066727A ECSP066727A EC SP066727 A ECSP066727 A EC SP066727A EC 2006006727 A EC2006006727 A EC 2006006727A EC SP066727 A ECSP066727 A EC SP066727A EC SP066727 A ECSP066727 A EC SP066727A
Authority
EC
Ecuador
Prior art keywords
tetrazol
bifenyl
derivatives
preparation
coupling reactions
Prior art date
Application number
EC2006006727A
Other languages
English (en)
Inventor
Hans Hirt
Christoph Krell
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of ECSP066727A publication Critical patent/ECSP066727A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

La presente invención se refiere a un proceso para la fabricación de intermediarios que se pueden utilizar para la fabricación de ARBs (también denominados como antagonistas del receptor de angiotensina II ó antagonistas del receptor AT1), los cuales comprenden, como una característica estructural común, un anillo de (1H-tetrazol-5-il)-bifenilo
EC2006006727A 2004-02-02 2006-07-26 Reacciones de acoplamiento útiles en la preparación de derivados de (1h-tetrazol-5-il)-bifenilo ECSP066727A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0402262.0A GB0402262D0 (en) 2004-02-02 2004-02-02 Process for the manufacture of organic compounds

Publications (1)

Publication Number Publication Date
ECSP066727A true ECSP066727A (es) 2006-10-31

Family

ID=31985494

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2006006727A ECSP066727A (es) 2004-02-02 2006-07-26 Reacciones de acoplamiento útiles en la preparación de derivados de (1h-tetrazol-5-il)-bifenilo

Country Status (19)

Country Link
US (2) US7700784B2 (es)
EP (2) EP1716140A1 (es)
JP (1) JP2007519684A (es)
KR (1) KR20060128993A (es)
CN (1) CN100528868C (es)
AU (1) AU2005211500B2 (es)
BR (1) BRPI0507352A (es)
CA (1) CA2553246A1 (es)
CO (1) CO5700717A2 (es)
EC (1) ECSP066727A (es)
GB (1) GB0402262D0 (es)
IL (2) IL176904A0 (es)
MA (1) MA28427B1 (es)
NO (1) NO20063920L (es)
NZ (1) NZ548690A (es)
RU (2) RU2426728C2 (es)
TN (1) TNSN06238A1 (es)
WO (1) WO2005075462A1 (es)
ZA (1) ZA200605462B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0222056D0 (en) * 2002-09-23 2002-10-30 Novartis Ag Process for the manufacture of organic compounds
JP5023720B2 (ja) * 2006-08-04 2012-09-12 東ソー株式会社 ハロゲン化ビフェニル類の製造方法
PL2295035T3 (pl) * 2007-11-06 2016-11-30 Podwójne działanie kompozycji farmaceutycznych opartych na superstrukturach antagonisty/blokera receptora angiotensyny (arb) oraz inhibitora obojętnej endopeptydazy (nep)
PE20091364A1 (es) 2008-01-17 2009-10-13 Novartis Ag Proceso para la preparacion de inhibidores de nep
JP5203144B2 (ja) * 2008-11-07 2013-06-05 東ソー株式会社 スチレン類の製造方法
JP5261140B2 (ja) * 2008-11-07 2013-08-14 東ソー株式会社 ビニル芳香族化合物の製造方法
EP2609075B1 (en) 2010-08-23 2016-03-16 Novartis AG Process for the preparation of intermediates for the manufacture of nep inhibitors
SG187843A1 (en) * 2010-08-27 2013-03-28 Teijin Pharma Ltd Method for producing phenyl-substituted heterocyclic derivative by means of coupling method using a palladium compound
CN103467341B (zh) * 2013-08-29 2015-02-25 河南师范大学 一种沙坦联苯的制备方法
CN104987327A (zh) * 2015-07-13 2015-10-21 朱绍清 一种四唑类衍生物的催化合成方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1334092C (en) 1986-07-11 1995-01-24 David John Carini Angiotensin ii receptor blocking imidazoles
US4820843A (en) * 1987-05-22 1989-04-11 E. I. Du Pont De Nemours And Company Tetrazole intermediates to antihypertensive compounds
US4874867A (en) * 1987-05-22 1989-10-17 E. I. Du Pont De Nemours And Company Tetrazole intermediates to antihypertensive compounds
DE69033469T2 (de) 1989-06-14 2000-09-07 Smithkline Beecham Corp., Philadelphia Imidazoalkensäure
ATE134624T1 (de) 1990-02-19 1996-03-15 Ciba Geigy Ag Acylverbindungen
GB9005354D0 (en) * 1990-03-09 1990-05-02 Glaxo Group Ltd Chemical compounds
TW201738B (es) 1990-03-20 1993-03-11 Sanofi Co
US5196444A (en) 1990-04-27 1993-03-23 Takeda Chemical Industries, Ltd. 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof
IE920540A1 (en) 1991-02-21 1992-08-26 Sankyo Co 1-biphenylmethylimidazole derivatives, their preparation and¹their therapetuic use
TW226375B (es) 1991-10-24 1994-07-11 American Home Prod
US5310928A (en) * 1991-11-18 1994-05-10 E. I. Du Pont De Nemours And Company Process for preparing biphenyltetrazole compounds
US5206374A (en) * 1991-11-18 1993-04-27 E. I. Du Pont De Nemours And Company Process for preparing tetrazolylphenylboronic acid intermediates
EP0550313A1 (fr) 1991-12-30 1993-07-07 Synthelabo Nouveaux dérivés de 2-(tétrazol-5-yl)-(1,1'-biphényle), leur préparation et leur utilisation comme intermédiaires de synthèse
FR2688503B1 (fr) 1992-03-16 1994-05-06 Synthelabo Procede de preparation de derives de 2-(tetrazol-5-yl)-[1,1'-biphenyle].
US5468867A (en) * 1994-05-27 1995-11-21 Syntex (U.S.A.) Inc. Process for preparing1-butyl-2-[2'-(2H-tetrazol-5-yl)biphenyl-4-ylmethyl1-1H-indole-3-carboxylic acid
PT788487E (pt) 1994-10-27 2001-11-30 Novartis Ag Processo para a preparacao de tetrazoles
JP3763869B2 (ja) * 1994-12-26 2006-04-05 東ソー・ファインケム株式会社 ビフェニル化合物の製造方法
US5922898A (en) * 1997-04-08 1999-07-13 Catalytica Pharmaceuticals, Inc. Process for preparing biaryl compounds
DE10057679A1 (de) 2000-11-21 2002-05-29 Forschungszentrum Juelich Gmbh Brennstoffzellenstapel mit Kreislaufführung
HRP20050082A2 (en) * 2002-07-19 2005-06-30 Memory Pharmaceuticals Corporation 6-amino-1h-indazole and 4-aminobenzofuran compounds as phosphodiesterase 4 inhibitors
GB0222056D0 (en) * 2002-09-23 2002-10-30 Novartis Ag Process for the manufacture of organic compounds
DE602004015071D1 (de) * 2003-02-05 2008-08-28 Teva Pharma Synthese von 2-butyl-3-(2'-(1-trityl-1h-tetrazol-5-yl)biphenyl-4-yl)-1,3-diazaspiro-4,4 -nonen-4-on
AU2004256042A1 (en) 2003-06-05 2005-01-20 Genentech, Inc. BlyS antagonists and uses thereof

Also Published As

Publication number Publication date
RU2010136996A (ru) 2012-03-20
IL176904A0 (en) 2006-12-10
RU2426728C2 (ru) 2011-08-20
KR20060128993A (ko) 2006-12-14
EP2246348A1 (en) 2010-11-03
MA28427B1 (fr) 2007-02-01
CN1914197A (zh) 2007-02-14
WO2005075462A1 (en) 2005-08-18
GB0402262D0 (en) 2004-03-10
CA2553246A1 (en) 2005-08-18
ZA200605462B (en) 2009-06-24
EP1716140A1 (en) 2006-11-02
BRPI0507352A (pt) 2007-07-03
NO20063920L (no) 2006-10-30
TNSN06238A1 (en) 2007-12-03
CN100528868C (zh) 2009-08-19
RU2006131460A (ru) 2008-03-10
AU2005211500A1 (en) 2005-08-18
US20070129413A1 (en) 2007-06-07
JP2007519684A (ja) 2007-07-19
IL208409A0 (en) 2011-08-01
US20100152458A1 (en) 2010-06-17
AU2005211500B2 (en) 2009-04-02
US7700784B2 (en) 2010-04-20
CO5700717A2 (es) 2006-11-30
NZ548690A (en) 2009-08-28

Similar Documents

Publication Publication Date Title
CL2012000429A1 (es) Uso de cepas de bifidobacterium longum para la elaboracion de una completa composicion que sirve para reducir los sintomas de alergias.
CR11776A (es) Inhibidores de bace
CL2012000921A1 (es) Compuestos derivados de espiropiperidina-metilbenciloxifenil, activadores del receptor rpg-40; composicion farmaceutica que los comprende; y uso del compuesto para tratar diabetes.
HN2010001563A (es) Compuestos
DOP2012000004A (es) Inhibidores de bace
AR069182A1 (es) Adhesivos de dispersion ii
SV2010003472A (es) Compuestos de pirazol
UA108209C2 (uk) Сполуки, які зв'язують фарнезоїдний х-рецептор (fxr,nr1h4) й модулюють його активність
PA8843901A1 (es) INHIBIDORES DE PIRIMIDINONA DE PI3K( ALFA) Y m TOR
ECSP10010245A (es) Peptidil nitrilos y uso de los mismos como inhibidores de dipeptidil peptidasa i
MX2010001837A (es) Derivados de 4-pirimidinasulfamida.
BRPI1008920A2 (pt) Composição farmacêutica para liberação de compostos inibidores de receptor de tirosina quinase (rtki) para o olho
CL2011000098A1 (es) Uso de una betadefensina de mamifero para tratar enfermedad inflamatoria.
GT201300078A (es) Proceso para la preparacion de inhibidores de pan-cdk de la formula ( i ), e intermediarios de la preparacion
ECSP088265A (es) Derivados de carboxamida como antagonistas del receptor muscarínico
EA201270280A1 (ru) Соединения пиримидина в качестве ингибиторов при лечении туберкулеза
UY32052A (es) 5-aminopirazoles sustituidos y uso de los mismos
ECSP088700A (es) Acidos 4-fenil-tiazol-5-carboxilicos y amidas de acidos 4-fenil-tiazol-5-carboxilicos como inhibidores de la plk1
HN2006014095A (es) Forma cristalina ortorrombica del maleato de asenapina
ECSP066727A (es) Reacciones de acoplamiento útiles en la preparación de derivados de (1h-tetrazol-5-il)-bifenilo
DK2346833T3 (da) Diazonium-fri fremgangsmåde til fremstilling af et indazolmellemprodukt i syntesen af bicyclisk 5-(trifluormethoxy)-1h-3-indazolcarboxylsyreamider
CL2012002954A1 (es) Compuestos derivados de heterobiaril-ciclohexil-tetraazabenzo[e]azules sustituidos, modulares del receptor de vasopresina v1a; procedimiento de preparacion; composicion farmaceutica; y su uso para la prevencion o el tratamient5o de la dismenorrea, disfuncion sexual masculina o femenina, ansiedad, hipertension, entre otros.
CL2012000272A1 (es) Proceso para la preparacion de (9-diclorometileno-1,2,3,4-tetrahidro-1,4-metano-naftalen-5-il)-amida del acido 3-difluorometil-1-metil-1h-pirazol-4-carboxilico; y los compuestos intermediarios considerados.
CR11828A (es) Compuestos novedosos activos como antagonistas de receptor muscarínico
UA101654C2 (uk) Матриксна фармацевтична композиція на основі гідросульфату (2-гідроксіетоксі)аміду 6-(4-бром-2-хлорфеніламіно)-7-фтор-3-метил-3н-бензоімідазол-5-карбонової кислоти